AC Immune S.A. (ACIU) Total Business Assets

Graphic logo of AC Immune Corp (ACIU)

AC Immune focuses on developing targeted treatments for neuronal degradation, maintaining its asset balance through payments from major partners. This daily price chart shows that the total asset volume is 212.69. The company minimizes losses by developing dementia treatments in collaboration with market leaders and implementing automated systems for accelerated biomaterial analysis.

AC Immune (ACIU): Cumulative Company Assets from 07/04/2022 to 10/28/2026

Analytical breakdowns for AC Immune Corp (ACIU)

- price and consensus price forecast:
Stock Price acimmune.com|ACIU - Price Target Chart
- market capitalization data:
Market Capitalization AC Immune Inc|ACIU - Enterprise Value
- book capitalization data:
Net Asset Value per Share AC Immune|ACIU - Company Net Assets|Market Capitalization to Book Value Ratio acimmune.com|ACIU - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio AC Immune|ACIU - Long-Term Debt to Equity|Current Liabilities to Capital AC Immune Inc|ACIU - Company Aggregate Debts|Debts to Book Capitalization AC Immune Inc|ACIU - Company Long-Term Debts|Company Current Liabilities AC Immune
Fundamental valuation:AC Immune
Finished products of AC Immune SA

Investors are assessing the potential of AC Immune (ACIU) through the company's ability to convert scientific capital into market value. This indicator reverse-engineers the total volume of resources via the return on assets (ROA) ratio to determine the actual scale of assets. The price action in the calculation of assets and resources reflects the financial foundation for retaining biomarker experts and the stability of the R&D core. Maintaining this volume confirms the resilience of the business model and the long-term attractiveness of the asset.

Key competitors

BIIB (biogen.com) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|Harmony Corp (HRMY) - Company Assets|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Company Total Assets TRVI (Trevi Therapeutics, Inc.)|Cumulative Company Assets Praxis Precision Medicines Inc PRAX|Cumulative Company Assets Anavex Corp|Aggregate Asset Value CeriBell EEG CBLL|Company Total Assets PRTA (Prothena Corporation plc)|ALEC: Company Total Asset Base|ANNX (Annexon) - Aggregate Company Assets|OMER (Omeros) - Cumulative Company Assets|Aggregate Company Assets NGNE|Cumulative Company Assets Voyager Corp (VYGR)|Cumulative Company Assets NMRA|Company Total Assets SCLX (scilexholding.com)|TVGN - Aggregate Company Assets|Total Business Assets Alpha Cognition Inc ACOG|CGTX (Cognition Therapeutics, Inc.) - Company Total Assets|IKT - Company Assets|SAVA: Company Total Assets|Assertio (ASRT) - Company Total Assets|Company Total Assets COYA|Cumulative Company Assets VistaGen Therapeutics Inc|OVID (Ovid Therapeutics Inc.) - Company Total Assets|Company Total Asset Base Acumen Pharmaceuticals, Inc ABOS|Cumulative Company Assets CRVO (CervoMed Inc.)|Alterity Therapeutics Ltd. - Company Total Assets|Clene Nanomedicine (CLNN) - Aggregate Company Assets|PEPG - Total Business Assets|Company Total Assets JUNS|Company Assets Relmada Corp|ANVS (Annovis Bio, Inc.) - Cumulative Company Assets|Company Total Assets GRCE|Firefly Neuroscience (AIFF) - Aggregate Company Assets|Aggregate Asset Value KLTO (anewmeds.com)|NRSN: Aggregate Company Assets|Company Assets Reviva Pharmaceuticals, Inc. RVPH|MetaVia, Inc. - Company Total Assets|NRXS - Company Total Assets|HSDT (heliusmedical.com) - Company Total Assets|Cumulative Company Assets Passage Bio|NEUP - Cumulative Company Assets|Aggregate Asset Value Minerva|ATHA (Athira Pharma, Inc.) - Company Total Assets|Company Total Asset Base ADXN (addextherapeutics.com)|Alzamend Neuro - Aggregate Company Assets|Cyclerion Therapeutics Inc. - Cumulative Company Assets|PTIX: Aggregate Company Assets|Pasithea Therapeutics (KTTA) - Cumulative Company Assets|CRGT: Cumulative Company Assets|ATXI (avenuetx.com) - Company Total Assets|Aggregate Company Assets BrainStorm Cell Therapeutics (BCLI)|Total Business Assets Cara Therapeutics Inc.|Chromocell Therapeutics Corporation - Company Total Assets|Company Assets eliemtx.com (ELYM)|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|Company Total Assets longboardpharma.com LBPH|MRNS: Company Total Assets|NKGN - Cumulative Company Assets|NeuroBo - Company Total Assets|Company Total Asset Base Sage Therapeutics Inc|SNPX (Synaptogenix, Inc.) - Cumulative Company Assets|Company Total Assets TRVN|Aggregate Company Assets Vigil Neuroscience VIGL|Total Business Assets anewmeds.com (WENA)|CERE: Company Total Assets